메뉴 건너뛰기




Volumn 17, Issue 1, 2009, Pages 10-15

Vasopressin and vasopressin receptor antagonists in heart failure

Author keywords

Aquaresis; Congestive heart failure; Receptors; Vasopressin; Vasopressin antagonists

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ARGIPRESSIN; ARGIPRESSIN RECEPTOR; CONIVAPTAN; DESMOPRESSIN; DIURETIC AGENT; ELECTROLYTE; FUROSEMIDE; LIXIVAPTAN; MOZAVAPTAN; TERLIPRESSIN; TOLVAPTAN; WATER; ANTIDIURETIC AGENT; VASOPRESSIN RECEPTOR;

EID: 59849121934     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e318190e72c     Document Type: Review
Times cited : (33)

References (86)
  • 1
    • 0014083093 scopus 로고
    • Biosynthesis and release of vasopressin
    • Sachs H. Biosynthesis and release of vasopressin. Am J Med. 1967;42:687- 700.
    • (1967) Am J Med , vol.42 , pp. 687-700
    • Sachs, H.1
  • 2
    • 0001954286 scopus 로고
    • The purification and the amino acid content of vasopressin preparations
    • Turner RA, Pierce JG, Du Vigneaud V. The purification and the amino acid content of vasopressin preparations. J Biol Chem. 1951;191:21-28.
    • (1951) J Biol Chem , vol.191 , pp. 21-28
    • Turner, R.A.1    Pierce, J.G.2    Du Vigneaud, V.3
  • 3
    • 33746875642 scopus 로고
    • An investigation of the free amino groups on oxytocin and desulfurized oxytocin preparations
    • Davoll H, Turner RA, Pierce JG, et al. An investigation of the free amino groups on oxytocin and desulfurized oxytocin preparations. J Biol Chem. 1951;193:363-370.
    • (1951) J Biol Chem , vol.193 , pp. 363-370
    • Davoll, H.1    Turner, R.A.2    Pierce, J.G.3
  • 4
    • 0024801647 scopus 로고
    • Discovery, development, and some uses of vaso-pressin and oxytocin antagonists
    • Manning M, Sawyer W. Discovery, development, and some uses of vaso-pressin and oxytocin antagonists. J Lab Clin Med. 1989;114:617-632.
    • (1989) J Lab Clin Med , vol.114 , pp. 617-632
    • Manning, M.1    Sawyer, W.2
  • 5
    • 67649987273 scopus 로고    scopus 로고
    • Vasopressin and vasopressin-receptor antagonists in the treatment of cardiovascular disease
    • Frishman WH, Sonnenblick EH, Sica DA, eds, 2nd ed. New York, NY: McGraw Hill
    • Frishman WH, Klapholz M, Acharya N, et al. Vasopressin and vasopressin-receptor antagonists in the treatment of cardiovascular disease. In: Frishman WH, Sonnenblick EH, Sica DA, eds. Cardiovascular Pharmacotherapeutics. 2nd ed. New York, NY: McGraw Hill. 2003:601-616.
    • (2003) Cardiovascular Pharmacotherapeutics , pp. 601-616
    • Frishman, W.H.1    Klapholz, M.2    Acharya, N.3
  • 6
    • 0028134886 scopus 로고
    • Cloning and characterization of the human V3 pituitary vasopressin receptors
    • DeKeyzer Y, Auzan C, Lenne F, et al. Cloning and characterization of the human V3 pituitary vasopressin receptors. FEBS Lett. 1994;345:215-220.
    • (1994) FEBS Lett , vol.345 , pp. 215-220
    • DeKeyzer, Y.1    Auzan, C.2    Lenne, F.3
  • 7
    • 0027270809 scopus 로고
    • Renal and central vasopressin receptors: Immunocytochemical localization
    • Fahrenholz F, Jurzak M, Gerstberger R, et al. Renal and central vasopressin receptors: immunocytochemical localization. Ann NY Acad Sci. 1993;689: 194-206.
    • (1993) Ann NY Acad Sci , vol.689 , pp. 194-206
    • Fahrenholz, F.1    Jurzak, M.2    Gerstberger, R.3
  • 8
    • 0021743563 scopus 로고
    • The anterior wall of the third cerebral ventricle and homeostatic responses to dehydration
    • McKinley MJ, Congiu M, Denton DA, et al. The anterior wall of the third cerebral ventricle and homeostatic responses to dehydration. J Physiol-Paris. 1984;79:421-427.
    • (1984) J Physiol-Paris , vol.79 , pp. 421-427
    • McKinley, M.J.1    Congiu, M.2    Denton, D.A.3
  • 9
    • 0025977407 scopus 로고
    • The role of arginine vasopressin for pineal melatonin synthesis in the rat: Involvement of vasopressinergic recep-tors
    • Stehle J, Reuss S, Riemann R, et al. The role of arginine vasopressin for pineal melatonin synthesis in the rat: involvement of vasopressinergic recep-tors. Neurosci Lett. 1991;123:131-134.
    • (1991) Neurosci Lett , vol.123 , pp. 131-134
    • Stehle, J.1    Reuss, S.2    Riemann, R.3
  • 10
    • 0024361515 scopus 로고
    • Criteria for establishment of a physiological role for brain peptides. A case in point: The role of vasopressin in thermoregulation during fever and antipyresis
    • Kasting NW. Criteria for establishment of a physiological role for brain peptides. A case in point: the role of vasopressin in thermoregulation during fever and antipyresis. Brain Res Rev. 1989;14:143-153.
    • (1989) Brain Res Rev , vol.14 , pp. 143-153
    • Kasting, N.W.1
  • 11
    • 0021683051 scopus 로고
    • Hypothermia induced by centrally adminis- tered vasopressin in rats: A structure-activity study
    • Meisenberg G, Simmons WH. Hypothermia induced by centrally adminis- tered vasopressin in rats: a structure-activity study. Neuropharmacol. 1984; 23:1195-1200.
    • (1984) Neuropharmacol , vol.23 , pp. 1195-1200
    • Meisenberg, G.1    Simmons, W.H.2
  • 12
    • 0024313636 scopus 로고
    • Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons
    • Whitnall MH. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. Neuroendocrin. 1989;50:702-707.
    • (1989) Neuroendocrin , vol.50 , pp. 702-707
    • Whitnall, M.H.1
  • 13
    • 0022587582 scopus 로고
    • Vasopressin and oxytocin: Hypothalamic modulators of the stress response: a review
    • Gibbs DM. Vasopressin and oxytocin: hypothalamic modulators of the stress response: a review. Psychoneuroendocrinol. 1986;11:131-139.
    • (1986) Psychoneuroendocrinol , vol.11 , pp. 131-139
    • Gibbs, D.M.1
  • 14
    • 0027402459 scopus 로고
    • Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats
    • Diamant M, DeWied D. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats. Am J Physiol. 1993;264: R51-R61.
    • (1993) Am J Physiol , vol.264
    • Diamant, M.1    DeWied, D.2
  • 17
    • 0019379071 scopus 로고
    • Relative contributions of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anaesthetized water deprived rat
    • Andrews CE, Brenner BM. Relative contributions of arginine vasopressin and angiotensin II to maintenance of systemic arterial pressure in the anaesthetized water deprived rat. Circ Res. 1981;48:254-258.
    • (1981) Circ Res , vol.48 , pp. 254-258
    • Andrews, C.E.1    Brenner, B.M.2
  • 18
    • 0020858968 scopus 로고
    • Contribution of vasopressin to the maintenance of blood pressure during dehydration
    • Woods RL, Johnston CI. Contribution of vasopressin to the maintenance of blood pressure during dehydration. Am J Physiol. 1983;245(5 Pt 1):F615-F621.
    • (1983) Am J Physiol , vol.245 , Issue.5 PART 1
    • Woods, R.L.1    Johnston, C.I.2
  • 19
    • 0014883371 scopus 로고
    • Intestinal vasoconstriction after hemorrhage: Roles of vasopressin and angiotensin
    • McNeill JR, Stark RD, Greenway CV. Intestinal vasoconstriction after hemorrhage: roles of vasopressin and angiotensin. Am J Physiol. 1970;219:1342-1347.
    • (1970) Am J Physiol , vol.219 , pp. 1342-1347
    • McNeill, J.R.1    Stark, R.D.2    Greenway, C.V.3
  • 20
    • 0020028964 scopus 로고
    • Role of vasopressin in abnormal water excretion in cirrhotic patients
    • Bichet D, Szatalowicz V, Chaimovitz C, et al. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med. 1982;96:413-417.
    • (1982) Ann Intern Med , vol.96 , pp. 413-417
    • Bichet, D.1    Szatalowicz, V.2    Chaimovitz, C.3
  • 21
    • 0028286789 scopus 로고
    • Therapeutic efficacy of the non-peptide AVP antagonist OPC 31260 in cirrhotic rats
    • Tsuboi Y, Ishikawa S, Fujisawa G, et al. Therapeutic efficacy of the non-peptide AVP antagonist OPC 31260 in cirrhotic rats. Kidney Int. 1994;46: 237-244.
    • (1994) Kidney Int , vol.46 , pp. 237-244
    • Tsuboi, Y.1    Ishikawa, S.2    Fujisawa, G.3
  • 22
    • 0023624247 scopus 로고
    • Receptors mediating the CRH effects of vasopressin and oxytocin
    • Antoni FA. Receptors mediating the CRH effects of vasopressin and oxytocin. Ann NY Acad Sci. 1987;512:195-204.
    • (1987) Ann NY Acad Sci , vol.512 , pp. 195-204
    • Antoni, F.A.1
  • 23
    • 0021955473 scopus 로고
    • A novel type of vasopressin receptor on anterior pituitary corticotrophs
    • Baertschi AJ, Friedli M. A novel type of vasopressin receptor on anterior pituitary corticotrophs. Endocrinol. 1985;116:499-502.
    • (1985) Endocrinol , vol.116 , pp. 499-502
    • Baertschi, A.J.1    Friedli, M.2
  • 24
    • 0014400427 scopus 로고
    • Renal adenyl cyclase: Anatomically separate sites for parathyroid hormone and vasopressin
    • Chase LR, Aurbach GD. Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin. Science. 1968;159:545-547.
    • (1968) Science , vol.159 , pp. 545-547
    • Chase, L.R.1    Aurbach, G.D.2
  • 25
    • 0017752156 scopus 로고
    • Rapid stimulation by vasopressin and adrenaline of inorganic phosphate incorporation into phosphatidyl inositol in isolated hepatocytes
    • Kirk CJ, Verrinder TR, Hems DA. Rapid stimulation by vasopressin and adrenaline of inorganic phosphate incorporation into phosphatidyl inositol in isolated hepatocytes. FEBS Lett. 1977;83:267-271.
    • (1977) FEBS Lett , vol.83 , pp. 267-271
    • Kirk, C.J.1    Verrinder, T.R.2    Hems, D.A.3
  • 26
    • 0018253517 scopus 로고
    • Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and anti-diuretic actions: Effects of highly potent analogues and competitive inhibitors
    • Butlen D, Guillon G, Rajerison RM, et al. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and anti-diuretic actions: effects of highly potent analogues and competitive inhibitors. Molec Pharmacol. 1978;14:1006-1017.
    • (1978) Molec Pharmacol , vol.14 , pp. 1006-1017
    • Butlen, D.1    Guillon, G.2    Rajerison, R.M.3
  • 27
    • 0018666457 scopus 로고
    • Hormonal stimulation of phosphatidylino-sitol breakdown with particular reference to the hepatic effects of vasopressin
    • Michell RK, Kirk CJ, Billah MM. Hormonal stimulation of phosphatidylino-sitol breakdown with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans. 1979;7:861-865.
    • (1979) Biochem Soc Trans , vol.7 , pp. 861-865
    • Michell, R.K.1    Kirk, C.J.2    Billah, M.M.3
  • 28
    • 0022610618 scopus 로고
    • Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line
    • Aiyar N, Nambi P, Stassen FL, et al. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Life Sci. 1986;39:37-45.
    • (1986) Life Sci , vol.39 , pp. 37-45
    • Aiyar, N.1    Nambi, P.2    Stassen, F.L.3
  • 29
    • 0021257890 scopus 로고
    • Novel ligand specificity of pituitary vasopressin receptors in the rat
    • Antoni FA. Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrin. 1984;39:186-188.
    • (1984) Neuroendocrin , vol.39 , pp. 186-188
    • Antoni, F.A.1
  • 32
    • 0022973734 scopus 로고
    • Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line
    • Nambi P, Whitman M, Gessner G, et al. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line. Proc Natl Acad Sci USA. 1986;83:8492-8495.
    • (1986) Proc Natl Acad Sci USA , vol.83 , pp. 8492-8495
    • Nambi, P.1    Whitman, M.2    Gessner, G.3
  • 34
    • 0021815931 scopus 로고
    • Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [arg]vasopressin in vascular smooth muscle cell
    • Nabika T, Velletri PA, Lovenberg W, et al. Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [arg]vasopressin in vascular smooth muscle cell. J Biol Chem. 1985;260:4661-4670.
    • (1985) J Biol Chem , vol.260 , pp. 4661-4670
    • Nabika, T.1    Velletri, P.A.2    Lovenberg, W.3
  • 35
    • 0031405967 scopus 로고    scopus 로고
    • Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells
    • Tahara A, Tomura Y, Wada K, et al. Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells. J Cardiovasc Pharmacol. 1997;30 759-766.
    • (1997) J Cardiovasc Pharmacol , vol.30 , pp. 759-766
    • Tahara, A.1    Tomura, Y.2    Wada, K.3
  • 36
    • 0033014807 scopus 로고    scopus 로고
    • Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells
    • Tahara A, Saito M, Tsukada J, et al. Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells. Eur J Pharmacol. 1999;26:89-94.
    • (1999) Eur J Pharmacol , vol.26 , pp. 89-94
    • Tahara, A.1    Saito, M.2    Tsukada, J.3
  • 37
    • 0024347882 scopus 로고
    • 2-agonism in dogs
    • 2-agonism in dogs. Am J Physiol. 1989;256:H1621-H1626.
    • (1989) Am J Physiol , vol.256
    • Liard, J.F.1
  • 38
    • 0026611957 scopus 로고
    • 1-vascular vasopressin receptors
    • 1-vascular vasopressin receptors. Reg Peptides. 1992;38:1-11.
    • (1992) Reg Peptides , vol.38 , pp. 1-11
    • Thibonnier, M.1
  • 39
    • 0025870505 scopus 로고
    • Current understanding of the cellular biology and molecular structure of antidiuretic hormone-stimulated water transport pathway
    • Harris HW Jr, Strange K, Zeidel M. Current understanding of the cellular biology and molecular structure of antidiuretic hormone-stimulated water transport pathway. J Clin Invest. 1991;88:1-8.
    • (1991) J Clin Invest , vol.88 , pp. 1-8
    • Harris Jr, H.W.1    Strange, K.2    Zeidel, M.3
  • 40
    • 0024415848 scopus 로고
    • Vasopressin receptors in human seminal vesicles: Identification, pharmacologic characterization, and comparison with the vasopressin receptors present in the human kidney
    • Maggi M, Baldi E, Genazzani AD, et al. Vasopressin receptors in human seminal vesicles: identification, pharmacologic characterization, and comparison with the vasopressin receptors present in the human kidney. J Androl. 1989;10:393-400.
    • (1989) J Androl , vol.10 , pp. 393-400
    • Maggi, M.1    Baldi, E.2    Genazzani, A.D.3
  • 41
    • 0028364549 scopus 로고
    • Endocytosis of the vasopressin receptor
    • Kumar R. Endocytosis of the vasopressin receptor. Semin Nephrol. 1994;14: 357-367.
    • (1994) Semin Nephrol , vol.14 , pp. 357-367
    • Kumar, R.1
  • 42
    • 40749135917 scopus 로고    scopus 로고
    • Acute variceal bleeding: Pharmacological treatment and primary/secondary prophylaxis
    • Dell'Era A, de Franchis R, Iannuzzi F. Acute variceal bleeding: pharmacological treatment and primary/secondary prophylaxis. Best Pract Res Clin Gastroenterol. 2008;22:279-294.
    • (2008) Best Pract Res Clin Gastroenterol , vol.22 , pp. 279-294
    • Dell'Era, A.1    de Franchis, R.2    Iannuzzi, F.3
  • 43
    • 0021988346 scopus 로고
    • Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits
    • Undesser KP, Hasser EM, Haywood JR, et al. Interactions of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits. Circ Res. 1985;56:410-417.
    • (1985) Circ Res , vol.56 , pp. 410-417
    • Undesser, K.P.1    Hasser, E.M.2    Haywood, J.R.3
  • 44
    • 0025346650 scopus 로고
    • 1 receptors in the area postrema
    • 1 receptors in the area postrema. Circ Res. 1990;67:265-271.
    • (1990) Circ Res , vol.67 , pp. 265-271
    • Hasser, E.M.1    Bishop, V.S.2
  • 45
    • 0024463128 scopus 로고
    • Central nervous system mechanisms involved in inhibition of renal sympathetic nerve activity induced by arginine vasopressin
    • Suzuki S, Takeshita A, Imaizumi T, et al. Central nervous system mechanisms involved in inhibition of renal sympathetic nerve activity induced by arginine vasopressin. Circ Res. 1989;65:1390-1399.
    • (1989) Circ Res , vol.65 , pp. 1390-1399
    • Suzuki, S.1    Takeshita, A.2    Imaizumi, T.3
  • 46
    • 0028140156 scopus 로고
    • Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats
    • Malpas SC, Coote JH. Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats. Am J Physiol. 1994; 266:R228-R236.
    • (1994) Am J Physiol , vol.266
    • Malpas, S.C.1    Coote, J.H.2
  • 47
    • 0031025550 scopus 로고    scopus 로고
    • Sex differences in the cardiovascular and renal actions of vasopressin in conscious rats
    • Wang YX, Crofton JT, Share L. Sex differences in the cardiovascular and renal actions of vasopressin in conscious rats. Am J Physiol. 1997;272(1 pt 2):R370-R376.
    • (1997) Am J Physiol , vol.272 , Issue.1 PART 2
    • Wang, Y.X.1    Crofton, J.T.2    Share, L.3
  • 48
    • 0032553654 scopus 로고    scopus 로고
    • Sex differences in extracellular and intracellular calcium-mediated vascular reactivity to vasopressin in rat aorta
    • Eatman D, Stallone JN, Rutecki GW, et al. Sex differences in extracellular and intracellular calcium-mediated vascular reactivity to vasopressin in rat aorta. Eur J Pharmacol. 1998;20:207-216.
    • (1998) Eur J Pharmacol , vol.20 , pp. 207-216
    • Eatman, D.1    Stallone, J.N.2    Rutecki, G.W.3
  • 49
    • 0028155695 scopus 로고
    • 2-induced vasodilation in dogs
    • 2-induced vasodilation in dogs. Am J Physiol. 1994;26:H99-H106.
    • (1994) Am J Physiol , vol.26
    • Liard, J.F.1
  • 50
    • 0027994386 scopus 로고
    • Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: Hyponatremia, hypokalemia, and hypomagnesemia
    • Leier CV, Dei Cas L, Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J. 1994;128:254.
    • (1994) Am Heart J , vol.128 , pp. 254
    • Leier, C.V.1    Dei Cas, L.2    Metra, M.3
  • 51
    • 0025153828 scopus 로고
    • Comparison of neuro-endocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)
    • Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuro-endocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
    • (1990) Circulation , vol.82 , pp. 1724-1729
    • Francis, G.S.1    Benedict, C.2    Johnstone, D.E.3
  • 52
    • 0031011283 scopus 로고    scopus 로고
    • Role of vasopressin in essential hypertension: Racial differences
    • Bakris G, Bursztyn M, Gavras I, et al. Role of vasopressin in essential hypertension: racial differences. J Hyperten. 1997;15:545-550.
    • (1997) J Hyperten , vol.15 , pp. 545-550
    • Bakris, G.1    Bursztyn, M.2    Gavras, I.3
  • 53
    • 0025880776 scopus 로고
    • Role of vasopressin in clinical hypertension and congestive cardiac failure: Interaction with the sympathetic nervous system
    • Gavras H. Role of vasopressin in clinical hypertension and congestive cardiac failure: interaction with the sympathetic nervous system. Clin Chem. 1991; 37(10 Pt 2):1828-1830.
    • (1991) Clin Chem , vol.37 , Issue.10 PART 2 , pp. 1828-1830
    • Gavras, H.1
  • 54
    • 0028017360 scopus 로고
    • Prognostic value of neurohormonal activation in patients with an acute myocardial infarction: Effect of captopril
    • Rouleau JL, Packer M, Moye L, et al. Prognostic value of neurohormonal activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol. 1994;24:583-591.
    • (1994) J Am Coll Cardiol , vol.24 , pp. 583-591
    • Rouleau, J.L.1    Packer, M.2    Moye, L.3
  • 55
    • 33745712365 scopus 로고    scopus 로고
    • Water and sodium retention in edematous disorders: Role of vasopressin and aldosterone
    • Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med. 2006;119(suppl 1):S47-S53.
    • (2006) Am J Med , vol.119 , Issue.SUPPL. 1
    • Schrier, R.W.1
  • 56
    • 0022469780 scopus 로고
    • Sequential elimination of pressor mechanisms in severe hypertension in humans
    • Ribeiro A, Mulinari R, Gavras I, et al. Sequential elimination of pressor mechanisms in severe hypertension in humans. Hypertension. 1986;8(Suppl I):I-169.
    • (1986) Hypertension , vol.8 , Issue.SUPPL. I
    • Ribeiro, A.1    Mulinari, R.2    Gavras, I.3
  • 57
    • 0020652610 scopus 로고
    • Role of angiotensin and vasopressin on blood pressure of ganglionic blocked dogs
    • Houck PC, Fiksen-Olsen MJ, Briton SL, et al. Role of angiotensin and vasopressin on blood pressure of ganglionic blocked dogs. Am J Physiol. 1983;244:H115-H120.
    • (1983) Am J Physiol , vol.244
    • Houck, P.C.1    Fiksen-Olsen, M.J.2    Briton, S.L.3
  • 58
    • 0032988191 scopus 로고    scopus 로고
    • 2 receptor antagonist, in dogs with pacing-induced congestive heart failure
    • 2 receptor antagonist, in dogs with pacing-induced congestive heart failure. Eur J Pharmacol. 1999;376:239-246.
    • (1999) Eur J Pharmacol , vol.376 , pp. 239-246
    • Yatsu, T.1    Tomura, Y.2    Tahara, A.3
  • 60
    • 0022518427 scopus 로고
    • The adrenergic system and the release and pressor action of vasopressin
    • Gavras I, Hatinoglou S, Gavras H. The adrenergic system and the release and pressor action of vasopressin. Hypertension. 1986;8(Suppl II):163-167.
    • (1986) Hypertension , vol.8 , Issue.SUPPL. II , pp. 163-167
    • Gavras, I.1    Hatinoglou, S.2    Gavras, H.3
  • 61
    • 0028241011 scopus 로고
    • Treatment with cilazapril, angioten-sin converting enzyme inhibitor, changes the affinity of arginine vasopressin receptor in the kidney of the spontaneously hypertensive rat
    • Nishida N, Ogura Y, Yamauchi T, et al. Treatment with cilazapril, angioten-sin converting enzyme inhibitor, changes the affinity of arginine vasopressin receptor in the kidney of the spontaneously hypertensive rat. Res Commun Chem Pathol Pharm. 1994;84:143-152.
    • (1994) Res Commun Chem Pathol Pharm , vol.84 , pp. 143-152
    • Nishida, N.1    Ogura, Y.2    Yamauchi, T.3
  • 62
    • 0018945560 scopus 로고
    • The cardiovascular effect of vasopres-sin in relation to its plasma concentration in man and its relevance to high blood pressure
    • Khokhar AM, Slater JDH, Ma J, et al. The cardiovascular effect of vasopres-sin in relation to its plasma concentration in man and its relevance to high blood pressure. Clin Endocrin. 1980;13:259-266.
    • (1980) Clin Endocrin , vol.13 , pp. 259-266
    • Khokhar, A.M.1    Slater, J.D.H.2    Ma, J.3
  • 63
    • 0019947661 scopus 로고
    • Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure
    • Gavras H, Hatzinikolaou P, North WG, et al. Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure. Hypertension. 1982;4:400-405.
    • (1982) Hypertension , vol.4 , pp. 400-405
    • Gavras, H.1    Hatzinikolaou, P.2    North, W.G.3
  • 64
    • 0042354581 scopus 로고    scopus 로고
    • Diuretic use, progressive heart failure and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD)
    • Domanski M, Norman J, Pitt B, et al. Diuretic use, progressive heart failure and death in patients in the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll of Cardiol. 2003;42:705-708.
    • (2003) J Am Coll of Cardiol , vol.42 , pp. 705-708
    • Domanski, M.1    Norman, J.2    Pitt, B.3
  • 65
    • 0344420330 scopus 로고    scopus 로고
    • Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model
    • Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290:2581-2587.
    • (2003) JAMA , vol.290 , pp. 2581-2587
    • Lee, D.S.1    Austin, P.C.2    Rouleau, J.L.3
  • 66
    • 33644871184 scopus 로고    scopus 로고
    • Hyponatremia in patients with heart failure
    • De Luca L, Klein L, Udelson JE, et al. Hyponatremia in patients with heart failure. Am J Cardiol. 2005;96:19L-23L.
    • (2005) Am J Cardiol , vol.96
    • De Luca, L.1    Klein, L.2    Udelson, J.E.3
  • 67
    • 18844423537 scopus 로고    scopus 로고
    • Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study
    • Klein L, O'Connor CM, Leimberger JD, et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005;111:2454-2460.
    • (2005) Circulation , vol.111 , pp. 2454-2460
    • Klein, L.1    O'Connor, C.M.2    Leimberger, J.D.3
  • 69
    • 0032240078 scopus 로고    scopus 로고
    • 2-receptor antagonist: Pharmacologic profile and aquaretic effect by single and multiple oral dosing in rats
    • 2-receptor antagonist: pharmacologic profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther . 1998;287:860-867.
    • (1998) J Pharmacol Exp Ther , vol.287 , pp. 860-867
    • Yamamura, Y.1    Nakamura, S.2    Itoh, S.3
  • 70
    • 39749187298 scopus 로고    scopus 로고
    • 2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure
    • 2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. Biochemical Pharmacol. 2008;75:1322-1330.
    • (2008) Biochemical Pharmacol , vol.75 , pp. 1322-1330
    • Veeraveedu, P.T.1    Watanabe, K.2    Ma, M.3
  • 71
    • 0033965154 scopus 로고    scopus 로고
    • 2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats
    • 2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats. J Pharmacol Exp Ther. 2000;292:288-294.
    • (2000) J Pharmacol Exp Ther , vol.292 , pp. 288-294
    • Hirano, T.1    Yoshitaka, Y.2    Nakamura, S.3
  • 72
    • 0037904417 scopus 로고    scopus 로고
    • 2-receptor blockade with tolvaptan in patients with chronic heart failure: Results from a double-blind, randomized trial
    • 2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation. 2003;107:2690-2696.
    • (2003) Circulation , vol.107 , pp. 2690-2696
    • Gheorghiade, M.1    Niazi, I.2    Ouyang, J.3
  • 73
    • 11144355788 scopus 로고    scopus 로고
    • Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial
    • Gheorghiade M, Gattis WA, O'Connor CM, et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004;291:1963-1971.
    • (2004) JAMA , vol.291 , pp. 1963-1971
    • Gheorghiade, M.1    Gattis, W.A.2    O'Connor, C.M.3
  • 74
    • 33947719178 scopus 로고    scopus 로고
    • Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST Clinical Status Trials
    • Gheorghiade M, Konstam MA, Burnett JC Jr, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007;297:1332.
    • (2007) JAMA , vol.297 , pp. 1332
    • Gheorghiade, M.1    Konstam, M.A.2    Burnett Jr, J.C.3
  • 75
    • 33947713810 scopus 로고    scopus 로고
    • Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial
    • Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297:1319.
    • (2007) JAMA , vol.297 , pp. 1319
    • Konstam, M.A.1    Gheorghiade, M.2    Burnett Jr, J.C.3
  • 78
    • 0018897308 scopus 로고
    • 1(ß-mercapto-ß- cyclopentamethyl-eneproprionic acid)2-(O-methyl)tyrosine] argin vasopressin and [1-(ß-mercapto-ß, ß-cyclopenta-methyleneproprionic acid)] argin vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin
    • Kruszynski M, Lammeck B, Manning M, et al. [1(ß-mercapto-ß- cyclopentamethyl-eneproprionic acid)2-(O-methyl)tyrosine] argin vasopressin and [1-(ß-mercapto-ß, ß-cyclopenta-methyleneproprionic acid)] argin vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin J Med Chem. 1980;23:364-368.
    • (1980) J Med Chem , vol.23 , pp. 364-368
    • Kruszynski, M.1    Lammeck, B.2    Manning, M.3
  • 79
    • 0037823130 scopus 로고    scopus 로고
    • Vasopressin: A new target for the treatment of heart failure
    • Lee CR, Watkins M, Patteron JH, et al. Vasopressin: a new target for the treatment of heart failure. Am Heart J. 2003;146:9-18.
    • (2003) Am Heart J , vol.146 , pp. 9-18
    • Lee, C.R.1    Watkins, M.2    Patteron, J.H.3
  • 80
    • 0021276993 scopus 로고
    • 5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin
    • 5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin. Acta Endocrinol. 1984;106:52-55.
    • (1984) Acta Endocrinol , vol.106 , pp. 52-55
    • Laszlo, F.A.1    Csati, S.2    Balaspiri, L.3
  • 85
    • 0035856509 scopus 로고    scopus 로고
    • 2 vasopressin receptor antagonist in patients with advanced heart failure
    • 2 vasopressin receptor antagonist in patients with advanced heart failure. Circulation. 2001;104:2417-2423.
    • (2001) Circulation , vol.104 , pp. 2417-2423
    • Udelson, J.E.1    Smith, W.B.2    Hendrix, G.H.3
  • 86
    • 33646054125 scopus 로고    scopus 로고
    • 2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients
    • 2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients. J Am Coll Cardiol. 2006;47:1615-1621.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1615-1621
    • Abraham, W.T.1    Shamshirsaz, A.A.2    McFann, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.